Vertex Ventures China — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Regorregor.comFeb 2021
Regor is a drug discovery company that uses a computational platform (rCARD) to identify and optimize preclinical small-molecule candidates in metabolism, oncology, and immunology, which it licenses to pharmaceutical companies for clinical development.
AI & Machine LearningBiotechDeep TechShanghai, CN
Xiayang Qiu(Founder)in
Co-investorsLAVLilly Asia VenturesVertex Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.